SCHEMBL7700271

SCHEMBL7700271

C=CCCC(C)(C)CCO

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.33
ALOX15 P16050 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL733256 0.82
SCHEMBL8960648 0.82 TSHR (0.35) TSHRALDH1A1
SCHEMBL37771 0.78
SCHEMBL1243865 0.77
SCHEMBL163785 0.77 TSHR (0.48) TSHRALOX15ALDH1A1
SCHEMBL27495248 0.75 ALDH1A1 (0.33) TSHRALDH1A1
SCHEMBL21523578 0.74 TSHR (0.36) TSHRALDH1A1
SCHEMBL8419199 0.74
SCHEMBL8960638 0.73 TSHR (0.35) TSHRALDH1A1
SCHEMBL18478706 0.73 TSHR (0.52) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056716-B1 CYCLOHEXANEDIOLE DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2002-12-11 EP disclosed
US-6184422-B1 TREATMENT AND PREVENTION OF HYPERPROLIFERATIVE SKIN DISEASES; REVERSING CONDITIONS ASSOCIATED WITH PHOTODAMAGE; ANTITUMOR, -CARCINOGENIC AGENTS; PSORIASIS; DISORDERS OF NEOPLASTIC DISEASES; KERATINIZATION/KERATOSIS; ACNE; SEBORRHEA HOFFMAN-LA ROCHE INC. 2001-02-06 US disclosed
EP-1056716-A1 CYCLOHEXANEDIOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-12-06 EP disclosed
WO-1999043646-A1 CYCLOHEXANEDIOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed